Search results
BNP is frequently used in the evaluation of dyspnea and to assess risk and prognosis of patients with congestive heart failure (CHF). Rational use of BNP or NT-proBNP can improve patient care by: Helping to differentiate dyspnea in patients caused by pulmonary dysfunction from dyspnea caused by CHF.
Wzrost stężenia BNP i NT-proBNP w osoczu jest istotny w: rozpoznawaniu zastoinowej niewydolności serca, CHF (ang. congestive heart failure) u chorych z objawami niewydolności serca. testu w połączeniu z EKG wynosi 100%ocenie ciężkości i rokowań w niewydolności serca - korelacja z I i I.
Test Alere Triage® BNP jest przeznaczony do użytku z immunologicznymi systemami firmy Beckman Coulter Access do diagnostyki in vitro. Badanie polega na ilościowym pomiarze stężenia peptydu natriuretycznego typu B (BNP) w próbkach osocza z zastosowaniem EDTA jako antykoagulanta. Przeznaczenie Test Alere Triage® BNP jest przeznaczony do
B-Type Natriuretic Peptide (BNP) or N-Terminal-ProBNP (NT-proBNP) for Clinicians Version 3.0. Reviewed April 13, 2023 SYNOPSIS AND RELEVANCE BNP is frequently used in the evaluation of dyspnea and to assess risk and prognosis of patients with congestive heart failure (CHF). Rational use of BNP or NT-proBNP can improve patient care by: 1.
The i-STAT BNP test is an in vitro diagnostic test for the quantitative measurement of B-type natriuretic peptide (BNP) in whole blood or plasma samples using EDTA as the anticoagulant. BNP measurements can be used as an aid in the diagnosis and assessment of the severity of congestive heart failure. Method Explanation
Brain natriuretic peptide (BNP) levels are simple and objective measures of cardiac function. These measurements can be used to diagnose heart failure, including diastolic dysfunction, and...
The B-type or brain natriuretic peptide (BNP) assay, a 15-minute bedside blood test, is highly sensitive and fairly specific for diagnosing heart failure and is useful in evaluating suspected heart failure in outpatients and in emergency care.
